Skip to main content
William Gradishar, MD, Oncology, Chicago, IL

WilliamGradisharMD

Oncology Chicago, IL

Breast Cancer, Hematologic Oncology

Betsy Bramsen Professorship of Breast Oncology, Northwestern University Medical School

Dr. Gradishar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gradishar's full profile

Already have an account?

  • Office

    675 N Saint Clair St
    # Galter
    Chicago, IL 60611
    Phone+1 312-695-0990
    Fax+1 312-695-1106

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1986 - 1989
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1986
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1982

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1982 - 2026
  • FL State Medical License
    FL State Medical License 2013 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer  
    Denise A Yardley, William J Gradishar, JAMA Oncology
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing  
    William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health

Lectures

  • Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Pros and Cons of Extended Adjuvant Endocrine Therapy 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Other

Authored Content

  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

  • Inavolisib Regimen Extends PFS in PIK3CA-Mutated Advanced Breast Cancer
    Inavolisib Regimen Extends PFS in PIK3CA-Mutated Advanced Breast CancerOctober 31st, 2024
  • INAVO120 Trial Tests Inavolisib in HR+, HER2-, PIK3C-Alpha-Mutated Disease
    INAVO120 Trial Tests Inavolisib in HR+, HER2-, PIK3C-Alpha-Mutated DiseaseOctober 30th, 2024
  • Targeting Protein Interactions May Boost Antitumor Immunity in Breast Cancer
    Targeting Protein Interactions May Boost Antitumor Immunity in Breast CancerApril 29th, 2024
  • Join now to see all

Professional Memberships